Skip to main content

Table 2 Hormonal profile and ultrasound measurements in treatment groups

From: Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF

  Group 1-A r FSH + Low dose hCG < 40 y N = 49 Group 2-A r FSH < 40 y N = 67 P Value Group 1-B r FSH + Low dose hCG ≥ 40 y N = 39 Group 2-B r FSH ≥ 40 y N = 32 P Value
CD3 FSH (IU/L) 5.38 ± 2.61 5.78 ± 3.26 0.243 6.97 ± 2.1 7.42 ± 2.78 0.232
CD3 LH (IU/L) 3.55 ± 2.61 3.67 ± 0.58 0.19 3.63 ± 2.02 4.37 ± 2.85 0.119
CD3 E2 (pmol/L) 112.23 ± 131.99 114.73 ± 51.89 0.451 120.39 ± 105.46 123.84 ± 37.04 0.426
CD 3 Progesterone (nmol/L) 4.13 ± 2.42 3.33 ± 2.23 0.063 4.21 ± 2.07 5.57 ± 4.48 0.066
FSH (IU/ML) on day of HCG admin 13.35 ± 5.14 14.38 ± 6.35 0.486 17.38 ± 4.93 19.96 ± 5.83 0.037
Estradiol (pmol/L) on day of HCG admin 8354.51 ± 4171.09 8226.81 ± 5262.10 0.443 8692.51 ±4174.06 6858.54 ± 3461.78 0.027
Estradiol (pmol/L) at HCG admin/Mature egg 1296.84 ± 1154.87 935.25 ± 436.13 0.025 1933.70 ± 1475.24 2214.41 ± 1946.52 0.265
Progesterone (nmol/L) on day of HCG admin 8.54 ± 4.23 6.87 ± 3.49 0.016 7.59 ± 3.88 6.48 ± 2.38 0.081
Endometrial thickness (mm) on day of HCG admin 1.02 ± 0.27 1.04 ± 0.25 0.336 0.98 ± 0.25 0.921 ± .026 0.125
  1. Both groups were comparable with regard to their baseline hormonal profile.